rss
Thorax 60:1012-1018 doi:10.1136/thx.2005.045260
  • Asthma

Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma

Table 3

 Changes in lung function before and after treatment with etanercept

Before treatment After treatment Mean change from baseline p value
All values are mean (SE) except *geometric mean (95% CI).
†Change shown as doubling dilutions of methacholine.
FEV1 (l) 1.91 (0.5) 2.16 (0.6) 0.24 (0.18) 0.01
FVC (l) 2.55 (0.2) 2.88 (0.2) 0.33 (0.29) 0.03
Morning PEF (predicted %) 54.8 (5.6) 61.0 (5.8) 5.75 (5.65) 0.023
Evening PEF (predicted %) 55.3 (5.1) 63.9 (5.1) 8.04 (5.23) 0.005
Methacholine PC20 (mg/ml)* 0.21 (0.1 to 0.64) 1.28 (0.53 to 2.92) 2.5 (1.75)† 0.033

This Article


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.